Sheikh M. Umar
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939.
Journal: Technology in cancer research & treatment
Published: February 17, 2026
Biophysical and molecular characterization of HuR inhibitors, CMLD-2 and Dihydrotanshinone I (DHTS), in Triple Negative Breast Cancer (TNBC).
Journal: International journal of biological macromolecules
Published: February 17, 2025
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types.
Journal: Molecular biology reports
Published: January 23, 2024
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cells.
Journal: Cell biology international
Published: June 27, 2023
Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
Journal: Journal of cellular biochemistry
Published: October 15, 2022
Quercetin Impairs HuR-Driven Progression and Migration of Triple Negative Breast Cancer (TNBC) Cells.
Journal: Nutrition and cancer
Published: July 19, 2021
Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: April 24, 2021
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Journal: Experimental cell research
Published: August 27, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026